Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and SwitzerlandMickael Lothgren, Erna Ribnicsek, Louise Schmidt, Wolfgang Habacher, Jonas Lundkvist, Alena M Pfeil, Irina Biteeva, Polina Vrouchou, Andrea Bracco
21 February 2013
Development and validation of an HPLC method to determine the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in infusion solutionsMikołaj Piekarski, Anna Jelin'ska, Kamil Szymczak
26 June 2012
Highlights of Italian hospital pharmacy: experiences and researchIlaria Uomo, Valeria Fadda, Paolo Serra, Federica Locchi, Francesco Cattel, Nicoletta Ambrogi, Francesca Venturini
23 June 2012
Clinical pharmacology consultations for safety, education and profitLoretta S Loftus, Gerald H Sokol
2 February 2012
How well are we doing in treating cancer pain in Europe: key findings of the European Pain in Cancer reportNathan Cherny
29 February 2012
Pharmacological and clinical aspects of immediate release fentanyl preparations: criteria for selectionE J M Kuip, M L Zandvliet, R H J Mathijssen, C C D Van der Rijt
2 February 2012
Implementing improvements in medication safety through a multidisciplinary working groupConxita Mestres, Sonia Moreno
2 February 2012
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive ServiceNilesh Patel, Mohammed Taki, Paul Tunstell, Paul Forsey, Ben Forbes
2 February 2012
